Chendil Damodaran, a holder of a Ph.D. degree, who has a Doctorate in cancer biology from the University of Madras, is an Assistant Professor in the Department of Clinical and Reproductive Laboratory Sciences. The research focus of Dr. Damodaran’s laboratory is the identification of novel phytochemicals that are chemopreventive and/or chemotherapeutic with respect to prostate and breast cancer. Dr. Damodarans' research is supported by many agencies including the Department of Defense, National Institutes of Health, Komen Breast Cancer Foundation, Kentucky Lung Cancer Research Program, and American Cancer Society. With respect to prostate cancer, his laboratory is involved in identifying compounds that have antiprostate cancer activity. As an extension of the breast and prostate cancer research efforts, Dr. Damodaran is involved in synthesizing and testing the derivatives of the bioactive parent compounds detailed above; some compounds appear to be more effective than their parent compounds. Dr. Damodaran’s pursuit of drugs for cancer therapy from natural products contributes significantly to the identification of new drugs that might possibly cure cancer, arrest its development, or prevent its occurrence.
Biography Updated on 17 April 2014